Related Experiment Videos
Enhanced transport in a therapeutic transdermal system
A R Comfort1, S M Dinh, J Otte
1Ciba-Geigy Corporation, Basic Pharmaceutics Research, Ardsley, NY 10502.
Biomaterials
|November 1, 1990
Summary
This study developed a transdermal therapeutic device using ethanol for controlled drug delivery. The device demonstrated stable adhesion and consistent ethanol release through the skin for 24 hours.
Area of Science:
- Pharmaceutical Sciences
- Biomaterials Engineering
Background:
- Transdermal drug delivery systems (TDDS) offer advantages over conventional routes.
- Controlled release of enhancers and drugs via TDDS requires careful material selection and formulation.
- Ethanol's role as a penetration enhancer and its controlled release in TDDS warrant investigation.
Purpose of the Study:
- To develop a mechanically stable transdermal therapeutic device incorporating ethanol.
- To evaluate the controlled delivery of ethanol and drug through the skin.
- To assess the long-term stability and adhesion of the developed transdermal system.
Main Methods:
- Screening of various control membrane laminates for swelling and adhesion.
- Equilibration of membrane laminates with ethanolic solutions.
- In vitro skin permeation analysis to determine ethanol flux.
- Development and testing of a reservoir-type transdermal system.
Main Results:
- Identification of a mechanically stable control membrane laminate.
- Linear relationship observed between ethanol flux and ethanol volume fraction.
- Constant in vitro ethanol skin permeation rates maintained for 24 hours.
- Stable adhesion of the transdermal reservoir device over 16 weeks at 40°C.
Conclusions:
- A transdermal therapeutic device incorporating ethanol was successfully developed.
- The device ensures controlled release of drug and ethanol through the skin for 24 hours.
- The system exhibits excellent mechanical stability and long-term adhesion, suitable for therapeutic applications.